Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Allergan Capital SARL, 2.625% 15nov2028, EUR
XS1909193317

  • Placement amount
    500,000,000 EUR
  • Outstanding amount
    72,107,000 EUR
  • USD equivalent
    72,406,965.12 USD
  • Minimum Settlement Amount
    100,000 EUR
  • ISIN
    XS1909193317
  • Common Code
    190919331
  • CFI
    DBFNBR
  • FIGI
    BBG00MFJ7VQ9
  • Ticker
    AGN 2.625 11/15/28

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Files

Prospectus

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
Customize fields in the table
Found:
Show all fields
* Data is not available within the selected subscription
Latest data on
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
Allergan Capital SARL (formerly known as Actavis Capital SARL) is a subsidiary of Allergan PLC (formerly known as Actavis PLC).
  • Borrower
    Go to the issuer page
    Allergan Capital SARL
  • Full borrower / issuer name
    Allergan Capital SARL
  • Sector
    Corporate
  • Industry
    Miscellaneous Healthcare: Products and Services
  • SPV / Issuer
Volume
  • Placement amount
    500,000,000 EUR
  • Outstanding amount
    72,107,000 EUR
  • Outstanding face value amount
    72,107,000 EUR
  • USD equivalent
    72,406,965 USD
Nominal
  • Minimum Settlement Amount
    100,000 EUR
  • Outstanding face value
    *** EUR
  • Integral multiple
    *** EUR
  • Nominal
    1,000 EUR

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Early redemption terms

***

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***, ***, ***, ***, ***
  • Depository
    ***

Conversion and exchange

Additional information

***

Latest issues

Identifiers

  • ISIN
    XS1909193317
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • Common Code
    190919331
  • CFI
    DBFNBR
  • FIGI
    BBG00MFJ7VQ9
  • WKN
    A2RUA0
  • Ticker
    AGN 2.625 11/15/28
  • Type of security by CBR
    ***

Ratings

Bond classification

  • Senior Unsecured
  • Registered
  • Coupon bonds
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible

Restructuring

***

Registration is required to get access.